PATENT CLAIM ANALYSIS

Application Number: 15861688
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "235200"]

Abstract:
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Claim (Index 17):
A method of preventing, managing, treating or lessening the severity of a protein kinase-mediated disease in a patient by administering to the patient with the pharmaceutical composition of  claim 14 , wherein the protein kinase-mediated disease is a JAK-mediated disease, a FLT3-mediated disease, an Aurora-mediated disease, a proliferative disease, an autoimmune disease, an allergic disease, an inflammatory disease, a transplantation rejection, cancer, polycythemia vera, essential thrombocytosis, myelofibrosis, chronic myelogenous leukemia (CML), acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic obstruction pulmonary disease (COPD), asthma, systemic lupus erythematosis, cutaneous lupus erythematosis, lupus nephritis, dermatomyositis, Sjogren's syndrome, psoriasis, type I diabetes mellitus, allergic airway disease, sinusitis, eczema, hives, food allergies, allergies to insect venom, inflammatory bowel syndrome, Chron's disease, rheumatoid arthritis, juvenile arthritis, psoriatic arthritis, organ transplant rejection, tissue transplant rejection or cell transplant rejection.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.48718
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15257926', '14670425', '14670421', '14670422', '15300284']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.797767710488588
- 35 USC 102 Novelty (BERT): 0.5722557651213509
- Combined Prediction Score: 0.7752165159518642
- Mean Citation Score: 402.676484
- Max Citation Score: 458.25174
- Similarity Product: 371.1000294068313

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test